Article Details

Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and Financial Results

Retrieved on: 2021-03-01 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and Financial Results. View article details on hiswai:

Excerpt

VIB7734 is an investigational monoclonal antibody designed to target and bind to ILT7, a cell surface molecule specific to pDCs, leading to their ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up